Comfort level of pediatricians and family medicine physicians diagnosing and treating child and adolescent psychiatric disorders

International Journal of Psychiatry in Medicine

Volumn 38, Issue 2, 2008, Pages 153-168

  Fremont, Wanda P ^a,c   Nastasi, Robert ^a   Newman, Nancy ^a   Roizen, Nancy J ^a,b  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Antidepressant black box warning; Diagnosis and treatment of child psychiatric disorders; Pediatricians and family medicine physicians; Prescribing psychotropic medications

Indexed keywords

AMPHETAMINE; ATOMOXETINE; CHLORPROMAZINE; DEXAMPHETAMINE; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; LITHIUM; PEMOLINE; PSYCHOTROPIC AGENT; RISPERIDONE; SERTRALINE; THIORIDAZINE;

ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR DISORDER; BIPOLAR MANIA; CHILD PSYCHIATRY; CLINICAL PRACTICE; DEPRESSION; DIAGNOSTIC ACCURACY; ENURESIS; GENERAL PRACTITIONER; GILLES DE LA TOURETTE SYNDROME; MENTAL DISEASE; OBSESSIVE COMPULSIVE DISORDER; PEDIATRICIAN; PRESCRIPTIVE AUTHORITY; PSYCHOSIS; QUESTIONNAIRE;

ATTITUDE OF HEALTH PERSONNEL; CHILD; CHILD, PRESCHOOL; DATA COLLECTION; FEMALE; HUMANS; INTERNSHIP AND RESIDENCY; MALE; MENTAL DISORDERS; MIDDLE AGED; NEW YORK; PEDIATRICS; PHYSICIANS, FAMILY; PSYCHOTROPIC DRUGS;

EID: 57749170013     PISSN: 00912174     EISSN: 15413527     Source Type: Journal    
DOI: 10.2190/PM.38.2.c     Document Type: Article

References (30)

1. Roberts RE, Attkission CC, Rosenblatt A. Prevalence of psychopathology among children and adolescents. American Journal of Psychiatry 1998;155:715-725.
2. Costello EJ, Angold A, Burns BJ, Erkanli A, Stangl DK, Tweed DL. The Great Smoky Mountains Study of Youth. Functional impairment and serious emotional disturbance. Archives of General Psychiatry 1996;53:1137-1143.
3. Shaffer D, Fisher P, Dulcan MK, et al. The NIMH Diagnostic Interview Schedule for Children Version e.3 (DISC-2.3): Description, acceptability, prevalence rates, and performance in the MECA Study. Methods for Epidemiology of Child and Adolescent Mental Disorders Study. Journal of the American Academy of Child and Adolescent Psychiatry 1996;35:865-877.
4. Kelleher KJ, McInerny TK, Gardner WP, Childs GE, Wasserman RC. Increasing identification of psychosocial problems: 1979-1996. Pediatrics 2000;105:1313-1321
5. Thomas CR, Holzer CE. National distribution of child and adolescent psychiatrists. Journal of the American Academy of Child and Adolescent Psychiatry 1999;38:9-16.
6. Goodwin R, Gould MS, Blanco C, Olfson M. Prescription of psychotropic medications to youths in office-based practice. Psychiatric Services 2001;52:1081-1087.
7. National Institute of Mental Health. Treatment of children with mental disorders. Bethesda, MD: National Institute of Mental Health, National Institutes of Health, U.S. Department of Health and Human Services; 2004. (NIH Publication No. 00-4702).
8. Birmaher B, Brent DA, Benson S. Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. Washington, DC: AACAP Publications Department, 1998.
9. Bernstein GA, Kinlan J. Practice parameters for the assessment and treatment of children and adolescents with anxiety disorder. Washington, DC: AACAP Publications Department, 1998.
10. Dulcan M, Benson S. Practice parameters for the assessment and treatment of children, adolescents and adults with attention-deficit/ hyperactivity disorder. Washington, DC: AACAP Publications Department, 1997.
11. Volkman F, Cook E, Pomeroy J, Realmuto G, Tanguay P. Practice parameters for the assessment and treatment of children, adolescents and adults with autism and other pervasive developmental disorders. Washington, DC: AACAP Publications Department, 1999.
12. Greenhill L, Pliszka S, Dulcan M. Practice parameter for the use of stimulant medications in the treatment of children, adolescents and adults. Washington, DC: AACAP Publications Department, 2001.
13. Zito JM, Safer DJ, dosReis S, et al. Psychotropic practice patterns for youth: A 10-year prospective. Archives of Pediatric and Adolescent Medicine 2003;157:17-25.
14. Delate T, Gelenberg AJ, Simmons VA, Motheral BJ. Trends in the use of antidepressant in a national sample of commercially insured pediatric patients: 1998-2002. Psychiatric Services 2004;55:387-391.
15. Cooper WO, Arbogast PG, Ding J, Hickson GB, Fuchs CF, Ray WA. Trends in prescribing of antipsychotic medications for US children. Ambulatory Pediatrics 2006;6:79-83.
16. Angold A, Erkanli HL, Costello EJ. Stimulant treatment for children: A community perspective. Journal of the American Academy of Child and Adolescent Psychiatry 2000;39:925-984.
17. Olfson M, Gameroff MJ, Marcus SC, Waslick BD. Outpatient treatment of child and adolescent depression in the United States. Archives of General Psychiatry 2003;60:1236-1242.
18. Safer DJ. Should selective serotonin reuptake inhibitors be prescribed for children with major depressive and anxiety disorders? Pediatrics 2006;118:1248-1251
19. Kilgore C. Antidepressant prescriptions for youth drop 10%. Pediatric News 2005;39(3). Available at: http://www.epediatricnews.com
20. Rosack J. New data show declines in antidepressant prescribing. Psychiatric News 2005;40:1. Available at: http://pn.psychiatryonline.org/ cgi/content/short/40/17/1-a
21. U.S. Food and Drug Administration Center for Drug Evaluation and Research. Labeling change request letter for antidepressant medications. Rockville, MD: Available at: www.fda.gov/cder/drug/antidepressants/ SSRIlabelChange.htm. 2004.
22. Stettin GD, Yao J, Verbrugge RR, Aubert RE. Frequency of follow-up care for adult and pediatric patients during initiation of antidepressant therapy. American Journal of Managed Care 2006;12:453-461.
23. Williams J, Klinepeter K, Palmes G, Pulley A, Foy JM. Diagnosis and treatment of behavioral health disorders in pediatric practice. Pediatrics 2004;114:601-606.
24. Tinsley JA, Shadid GE, Li H, Offord KP, Agerter DC. A survey of family physicians and psychiatrists. Psychotropic prescribing practices and educational needs. General Hospital Psychiatry 1998;20:360-367.
25. Minde K. The use of psychotropic medications in preschoolers: Some recent developments. Canadian Journal of Psychiatry 1998;43:671-675.
26. March J, Silva S, Petrycki S, et al. Fluoxetine, cognitive-behavior therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. Journal of the American Medical Association 2004;292:807-820.
27. MTA Cooperative Group. A 14 month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Archives of General Psychiatry 1999;56:1073-1086.
28. Burns BJ, Costello EJ, Angold A, et al. Children's mental health service use across service sectors. Health Affairs (Millwood) 1995;14:147-159.
29. Thomas CR, Holzer CE. The continuing shortage of child and adolescent psychiatrists. Journal of the American Academy Child and Adolescent Psychiatry 2006;45:1023-1031.
30. Torstenson OL. The treatment of mood disorders in children and adolescents by general pediatricians. Biology and Psychiatry 2001;49:970-971.